InsiderClue
Stocks · Health care · Pharmaceutical Preparations

AN2 Therapeutics, Inc.

ANTX Clue Score37
United States Fiscal year ends December CIK 0001880438 Results filed 11 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

84
Insider
Date
Role
Action
Shares
Price
Amount
Sarah Joanne Williams
1 Sep 2026
Principal Accounting Officer
Sell
272
$5.53
$1.50K
Joshua M Eizen
8 Jul 2026
See Remarks
Sell
5,945
$4.17
$24.80K
Sarah Joanne Williams
29 May 2026
Principal Accounting Officer
Sell
265
$4.43
$1.17K
Sarah Joanne Williams
3 Mar 2026
Principal Accounting Officer
Sell
327
$1.06
$346.62
Joshua M Eizen
6 Jan 2026
See Remarks
Sell
6,931
$1.01
$7.01K
Sanjay Chanda
6 Jan 2026
Chief Development Officer
Sell
5,956
$1.01
$6.03K
Stephen David Prior
6 Jan 2026
Chief Strategy Officer
Sell
2,858
$1.01
$2.89K
Lucy Day
6 Jan 2026
Chief Financial Officer
Sell
5,512
$1.01
$5.58K
Joshua M Eizen
5 Jan 2026
See Remarks
Sell
17,923
$1.00
$17.95K
Sanjay Chanda
5 Jan 2026
Chief Development Officer
Sell
3,295
$1.00
$3.30K
Stephen David Prior
5 Jan 2026
Chief Strategy Officer
Sell
3,604
$1.00
$3.61K
Lucy Day
5 Jan 2026
Chief Financial Officer
Sell
3,295
$1.00
$3.30K
Stephen David Prior
4 Nov 2025
Chief Strategy Officer
Sell
765
$1.14
$872.10
Joshua M Eizen
4 Nov 2025
See Remarks
Sell
2,819
$1.14
$3.21K
Braden Michael Leonard
30 May 2025
10% owner
Sell indirect
7,000
$1.03
$7.23K
Braden Michael Leonard
30 May 2025
10% owner
Sell indirect
425,000
$1.01
$429.25K
Braden Michael Leonard
28 May 2025
10% owner
Sell indirect
100,000
$1.16
$116.00K
Braden Michael Leonard
28 May 2025
10% owner
Sell indirect
2,000,000
$1.16
$2.32M
Braden Michael Leonard
28 May 2025
10% owner
Sell indirect
200,000
$1.09
$218.00K
Joshua M Eizen
3 Jan 2025
See Remarks
Sell
9,663
$1.34
$12.96K
Stephen David Prior
3 Jan 2025
Chief Strategy Officer
Sell
2,029
$1.34
$2.72K
Sanjay Chanda
3 Jan 2025
Chief Development Officer
Sell
2,957
$1.34
$3.97K
Lucy Day
3 Jan 2025
Chief Financial Officer
Sell
2,957
$1.34
$3.97K
Ra Capital Management, L.p.
9 Aug 2024
10% owner
Sell indirect
114,759
$1.08
$123.94K
Ra Capital Management, L.p.
9 Aug 2024
10% owner
Sell indirect
3,410,335
$1.08
$3.68M
Joseph S Zakrzewski
18 Jan 2024
Director
Sell indirect
100,000
$19.11
$1.91M
Adjuvant Global Health Technology Fund, L.P.
16 Jan 2024
10% owner
Sell indirect
15,907
$19.65
$312.57K
Adjuvant Global Health Technology Fund, L.P.
16 Jan 2024
10% owner
Sell
84,093
$19.65
$1.65M
Kabeer Aziz
16 Jan 2024
Director
Sell indirect
15,907
$19.65
$312.57K
Kabeer Aziz
16 Jan 2024
Director
Sell indirect
84,093
$19.65
$1.65M
Adjuvant Global Health Technology Fund, L.P.
2 Oct 2023
10% owner
Sell indirect
902
$16.07
$14.50K
Adjuvant Global Health Technology Fund, L.P.
2 Oct 2023
10% owner
Sell
4,770
$16.07
$76.65K
Kabeer Aziz
2 Oct 2023
Director
Sell indirect
902
$16.07
$14.50K
Kabeer Aziz
2 Oct 2023
Director
Sell indirect
4,770
$16.07
$76.65K
Adjuvant Global Health Technology Fund, L.P.
29 Sep 2023
10% owner
Sell indirect
15,764
$16.28
$256.64K
Adjuvant Global Health Technology Fund, L.P.
29 Sep 2023
10% owner
Sell
83,337
$16.28
$1.36M
Kabeer Aziz
29 Sep 2023
Director
Sell indirect
15,764
$16.28
$256.64K
Kabeer Aziz
29 Sep 2023
Director
Sell indirect
83,337
$16.28
$1.36M
Kabeer Aziz
28 Sep 2023
Director
Sell indirect
1,356
$16.11
$21.85K
Kabeer Aziz
28 Sep 2023
Director
Sell indirect
7,160
$16.11
$115.35K
Adjuvant Global Health Technology Fund, L.P.
28 Sep 2023
10% owner
Sell indirect
1,356
$16.11
$21.85K
Adjuvant Global Health Technology Fund, L.P.
28 Sep 2023
10% owner
Sell
7,160
$16.11
$115.35K
Kabeer Aziz
27 Sep 2023
Director
Sell indirect
134
$16.07
$2.15K
Kabeer Aziz
27 Sep 2023
Director
Sell indirect
707
$16.07
$11.36K
Adjuvant Global Health Technology Fund, L.P.
27 Sep 2023
10% owner
Sell indirect
134
$16.07
$2.15K
Adjuvant Global Health Technology Fund, L.P.
27 Sep 2023
10% owner
Sell
707
$16.07
$11.36K
Adjuvant Global Health Technology Fund, L.P.
13 Sep 2023
10% owner
Sell indirect
64
$16.00
$1.02K
Adjuvant Global Health Technology Fund, L.P.
13 Sep 2023
10% owner
Sell
336
$16.00
$5.38K
Kabeer Aziz
13 Sep 2023
Director
Sell indirect
64
$16.00
$1.02K
Kabeer Aziz
13 Sep 2023
Director
Sell indirect
336
$16.00
$5.38K
Kabeer Aziz
7 Sep 2023
Director
Sell indirect
537
$16.05
$8.62K
Kabeer Aziz
7 Sep 2023
Director
Sell indirect
2,841
$16.05
$45.60K
Adjuvant Global Health Technology Fund, L.P.
7 Sep 2023
10% owner
Sell indirect
537
$16.05
$8.62K
Adjuvant Global Health Technology Fund, L.P.
7 Sep 2023
10% owner
Sell
2,841
$16.05
$45.60K
Kabeer Aziz
6 Sep 2023
Director
Sell indirect
598
$16.02
$9.58K
Kabeer Aziz
6 Sep 2023
Director
Sell indirect
3,164
$16.02
$50.69K
Adjuvant Global Health Technology Fund, L.P.
6 Sep 2023
10% owner
Sell indirect
598
$16.02
$9.58K
Adjuvant Global Health Technology Fund, L.P.
6 Sep 2023
10% owner
Sell
3,164
$16.02
$50.69K
Kabeer Aziz
23 Aug 2023
Director
Sell indirect
64
$16.00
$1.02K
Kabeer Aziz
23 Aug 2023
Director
Sell indirect
336
$16.00
$5.38K
Adjuvant Global Health Technology Fund, L.P.
23 Aug 2023
10% owner
Sell indirect
64
$16.00
$1.02K
Adjuvant Global Health Technology Fund, L.P.
23 Aug 2023
10% owner
Sell
336
$16.00
$5.38K
Eric Easom
14 Nov 2022
Chief Executive Officer
Sell
23
$15.04
$345.92
Eric Easom
10 Nov 2022
Chief Executive Officer
Sell
4,413
$15.32
$67.63K
Eric Easom
9 Nov 2022
Chief Executive Officer
Sell
10,111
$15.61
$157.85K
Eric Easom
8 Nov 2022
Chief Executive Officer
Sell
1,255
$16.38
$20.56K
Eric Easom
8 Nov 2022
Chief Executive Officer
Sell
5,800
$15.41
$89.39K
Eric Easom
7 Nov 2022
Chief Executive Officer
Sell
2,036
$16.72
$34.04K
Eric Easom
7 Nov 2022
Chief Executive Officer
Sell
10,167
$15.90
$161.71K
Eric Easom
4 Nov 2022
Chief Executive Officer
Sell
8,828
$15.80
$139.47K
Eric Easom
3 Nov 2022
Chief Executive Officer
Sell
3,083
$16.02
$49.38K
Eric Easom
3 Nov 2022
Chief Executive Officer
Sell
11,082
$15.67
$173.68K
Eric Easom
2 Nov 2022
Chief Executive Officer
Sell
1,544
$15.07
$23.26K
Eric Easom
31 Oct 2022
Chief Executive Officer
Sell
2,688
$15.39
$41.36K
Eric Easom
28 Oct 2022
Chief Executive Officer
Sell
1,683
$15.09
$25.39K
Eric Easom
27 Oct 2022
Chief Executive Officer
Sell
924
$15.36
$14.19K
Eric Easom
26 Oct 2022
Chief Executive Officer
Sell
1,678
$15.10
$25.34K
Eric Easom
25 Oct 2022
Chief Executive Officer
Sell
534
$16.20
$8.65K
Eric Easom
25 Oct 2022
Chief Executive Officer
Sell
4,272
$15.69
$67.02K
Eric Easom
24 Oct 2022
Chief Executive Officer
Sell
2,866
$16.17
$46.34K
Eric Easom
21 Oct 2022
Chief Executive Officer
Sell
2,350
$16.69
$39.23K
Eric Easom
21 Oct 2022
Chief Executive Officer
Sell
11,601
$16.29
$189.01K
Eric Easom
20 Oct 2022
Chief Executive Officer
Sell
31
$17.15
$531.50
Eric Easom
20 Oct 2022
Chief Executive Officer
Sell
7,262
$16.68
$121.14K
Show all 140 transactions →

What was left out

Form 4 filings counted 186
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 2
Sales at will 84
Transactions with no price 0
Shares from compensation/vesting 9,487,058
Sales filed before the plan box existed 22
History held since 31 Mar 2022